Create your Personal Health Record and unlock support built around you
- Treatments and trials you qualify for
- Education for your stage of care
- Financial support for your medications
- Solutions to your side effects
MRD Relapse vs Biochemical Relapse -Restarting Myeloma Therapy | Fredrik Schjesvold, MD, PhD #IMS25
HealthTreeDescription
When is the right time to restart treatment in multiple myeloma? Should therapy begin at the first signs of MRD (measurable residual disease) relapse, or is it better to wait until biochemical relapse appears? The REMNANT study (NCT04513639), which will evaluate outcomes of treatment given at measurable residual disease (MRD) relapse versus progressive disease to answer this question.
Watch the full course and our most up-to-date content here: https://linktr.ee/HealthTreeUniversity
Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer!
Patients have the key to find cures for cancer. Learn more about HealthTree Cure Hub here: https://healthtree.org/curehub?utm_source=social+media&utm_medium=htu+youtube&utm_campaign=htu-curehub&utm_content=general
Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.